Patients with nonmetastatic prostate cancer treated according to NCCN Guidelines are more likely to die of other natural ...

Chronic myelomonocytic leukemia (CMML) shares with other myeloid diseases a number of somatic gene mutations. These mutations can now be integrated within the framework of evolution theory to ...

Abstract Purpose To determine the maximum-tolerated dose (MTD), safety, pharmacokinetic and pharmacodynamic profiles, and clinical activity of an oral formulation of azacitidine in patients with ...

The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines. PLYMOUTH MEETING, Pa., June 24, 2025 /CNW/ -- The National Comprehensive Cancer Network ® (NCCN ® ...

The NCCN Guidelines for Patients ® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®.

The new interactive guideline tool represents a major format change for gold-standard NCCN Guidelines.

The new NCCN Guidelines Navigator™ presents the evidence-based, expert consensus-driven recommendations from the NCCN Guidelines in a virtual platform that allows users to search and navigate ...

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in ...